Intravascular Lithotripsy May Emerge as a First-Line Therapy for Calcified Lesions in Women

“Given the established safety profile of IVL and the high rates of acute and long-term adverse events in women undergoing PCI, with or without atheroablation of calcified lesions, coronary IVL is an attractive treatment option for optimizing outcomes in our female patients,” said Alexandra Lansk y, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine (Cardiology); Director of Yale Cardiovascular Clinical Research Program, Yale University School of Medicine, New Haven, Conn. “While this is the first one-year analysis of its kind for coronary IVL, the sustained benefit in MACE at one year sug gests that IVL should be considered first-line therapy for plaque modification in women with calcified lesions.”
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news